A telephone call was held yesterday between His Royal Highness Prince Salman bin Hamad Al Khalifa, the Crown Prince and Prime Minister, and Dr Reshma Kewalramani, CEO and President of Vertex Pharmaceuticals. HRH Prince Salman highlighted
TDT | Manama
Email: mail@newsofbahrain.com
A telephone call was held yesterday between His Royal Highness Prince Salman bin Hamad Al Khalifa, the Crown Prince and Prime Minister, and Dr Reshma Kewalramani, CEO and President of Vertex Pharmaceuticals.
HRH Prince Salman highlighted the Kingdom’s medical milestone in successfully completing the treatment of the world’s first sickle cell disease patient outside the US with Casgevy (exagamglogene autotemcel), a CRISPR-based gene-editing therapy using bone marrow transplantation technology.
He reaffirmed the importance of strengthening the Kingdom’s partnership with Vertex Pharmaceuticals to promote future opportunities that further support the Kingdom’s health sector.
His Royal Highness noted the Kingdom’s commitment to enhancing cooperation with leading international specialised medical institutions, ensuring the Kingdom remains at the forefront of scientific advancements.
He emphasised the importance of integrating cutting-edge treatments into healthcare and rehabilitation services for Bahrainis, underscoring this as a top priority.
